Natural products proposed for the management of Huntington’s disease (HD): a comprehensive review
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-04444-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Aya Salman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Egyptian Russian University, Badr City , Cairo, 11829, Egypt. Hauptthemen laut MEDLINE: Huntington Disease, Biological Products, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 288 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.
Abstract (Originalsprache)
Huntington’s disease (HD), a neurodegenerative disease, typically begins in the prime of adulthood, followed by a gradual onset of specific mental abnormalities and cognitive and physical impairment. To the best of our knowledge, no medication exists to totally stop the progression of HD. Among numerous therapy techniques, extensive literature reviews have confirmed the medicinal importance of natural products in HD experimental models. This review provides a literature survey of natural compounds and medicinal plants used as neuroprotective agents against HD. Relevant studies were found in a variety of scientific databases, including PubMed, ScienceDirect, Scopus, and Google Scholar. Overall, natural products provided various levels of neuroprotection in preclinical HD investigations through antioxidant and anti-inflammatory activities, mitochondrial function maintenance, apoptosis suppression, and autophagy induction. Plants such as Bacopa monnieri , Ginkgo biloba , Panax ginseng , and Withaniasomnifera were identified as the most promising anti-HD possibilities, with several of them known as CNS-active medicines. Curcumin, epigallocatechin-gallate, ginsenosides, kaempferol, naringin, and resveratrol were identified as anti-HD compounds, some of which are well recognized neuroprotectants. Further study is required to assess the therapeutic efficacy of new herbal extracts in HD animals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Egyptian Russian University, Badr City , Cairo, 11829, Egypt.
- Pharmacology and Toxicology Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt.
- Pharmacology and Toxicology Department, Faculty of Pharmacy6 of October City, Ahram Canadian University, Giza, 12566, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt. riham.adel@pharma.cu.edu.eg.
- Department of Pharmacognosy, Faculty of Pharmacy, Badr University in Cairo (BUC), Cairo, 11829, Egypt.
ORCID-Profile: Riham A El-Shiekh
Förderung
- Cairo University
Zitieren
APA
Salman, A., Eid, A. H., Khalaf, S. S., El-Dessouki, A. M., El-Shiekh, R. A., & Aly, S. H. (2025). Natural products proposed for the management of Huntington’s disease (HD): a comprehensive review. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04444-w
Vancouver
Salman A, Eid AH, Khalaf SS, El-Dessouki AM, El-Shiekh RA, Aly SH. Natural products proposed for the management of Huntington’s disease (HD): a comprehensive review. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04444-w
BibTeX
@article{Salman2025,
author = {Salman, Aya and Eid, Aya H and Khalaf, Samar S and El-Dessouki, Ahmed M and El-Shiekh, Riham A and Aly, Shaza H},
title = {Natural products proposed for the management of Huntington’s disease (HD): a comprehensive review},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-04444-w}
}
EUVIMED